EDGAR Filing Documents for 0001683168-23-008732

Form 8-K - Current report:

SEC Accession No. 0001683168-23-008732

Filing Date

2023-12-08

Accepted

2023-12-08 17:00:32

Documents

Period of Report

2023-12-06

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	phio_8k.htm iXBRL	8-K	34580
2	FORM OF SERIES A/B WARRANT	phio_ex0401.htm	EX-4.1	112889
3	FORM OF PLACEMENT AGENT WARRANT	phio_ex0402.htm	EX-4.2	113845
4	FORM OF INDUCEMENT LETTER AGREEMENT	phio_ex1001.htm	EX-10.1	51852
5	PRESS RELEASE	phio_ex9901.htm	EX-99.1	12014
9	GRAPHIC	image_001.jpg	GRAPHIC	2297
	Complete submission text file	0001683168-23-008732.txt		573892

Data Files

Seq	Description	Document	Type	Size
6	XBRL SCHEMA FILE	phio-20231206.xsd	EX-101.SCH	3021
7	XBRL LABEL FILE	phio-20231206_lab.xml	EX-101.LAB	34240
8	XBRL PRESENTATION FILE	phio-20231206_pre.xml	EX-101.PRE	22363
11	EXTRACTED XBRL INSTANCE DOCUMENT	phio_8k_htm.xml	XML	3326

Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752

Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861

Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)